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Abstract
Candida albicans is a commensal opportunistic pathogen, which can cause superficial infections as well as systemic
infections in immuocompromised hosts. Among nosocomial fungal infections, infections by C. albicans are associated with
highest mortality rates even though incidence of infections by other related species is on the rise world over. Since C.
albicans and other Candida species differ in their susceptibility to antifungal drug treatment, it is crucial to accurately
identify the species for effective drug treatment. Most diagnostic tests that differentiate between C. albicans and other
Candida species are time consuming, as they necessarily involve laboratory culturing. Others, which employ highly sensitive
PCR based technologies often, yield false positives which is equally dangerous since that leads to unnecessary antifungal
treatment. This is the first report of phage display technology based identification of short peptide sequences that can
distinguish C. albicans from other closely related species. The peptides also show high degree of specificity towards its
different morphological forms. Using fluorescence microscopy, we show that the peptides bind on the surface of these cells
and obtained clones that could even specifically bind to only specific regions of cells indicating restricted distribution of the
epitopes. What was peculiar and interesting was that the epitopes were carbohydrate in nature. This gives insight into the
complexity of the carbohydrate composition of fungal cell walls. In an ELISA format these peptides allow specific detection
of relatively small numbers of C. albicans cells. Hence, if used in combination, such a test could help accurate diagnosis and
allow physicians to initiate appropriate drug therapy on time.
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Introduction
Candida albicans is an opportunistic human fungal pathogen of the
gastrointestinal and genitourinary tracts [1]. Infections with C.
albicans, a commensal in healthy individuals is associated with
immunocompromised conditions in patients and delayed treatment
of systemic infections can lead to increased mortality rates [2]. Early
initiation of anti-fungal drug therapy depends on proper diagnosis of
the pathogen. For routine identification of Candida isolates,
conventional methods including germ tube formation, chlamydo-
spore formation and sugar assimilation tests are universally accepted
[3]. However, except for germ tube formation, other culturing
techniques are time consuming, and can take up to 3 weeks. In
immunocompromised patients, the clinical appearance of C. albicans
infection is often very complex and identification of the species is
difficult [4]. Lack of a reliable early diagnosis can lead to
unnecessary arbitrary treatment of patients with antifungals that
are toxic and expensive [5]. Many groups have developed PCR
based assays for detection and identification of medically important
yeast species [6], [7]. However, these methods which claim high
sensitivity also require greater technical skills as well as expensive
instrumentation and are likely to yield false positive results. In such a
scenario, rapid identification methods using simple ELISA could be
more useful compared to expensive PCR based assays or time
consuming traditional culture based methods.
Stable short peptide sequences find their use as antimicrobial
agents against many pathogens [8]. It is reported that histidine-rich
peptides called Histatins are present in human parotid and sub-
mandibular saliva. Histatins mediate killing of C. albicans by causing
leakage of intracellular potassium ions and ATP [9], [10]. Similarly,
other short peptides which specifically bind to the cell surface of C.
albicans, may find important place in the area of diagnosis. Here, we
present first report of identification of 12 mer peptides derived from
a phage displayed peptide library selected against the filamentous
form of C. albicans. We show that these peptides can successfully
distinguish C. albicans from six other closely related Candida species
and propose that they can be used as reagents in diagnostic tests.
Results
Phage display selection allowed identification of several
Candida albicans specific clones
As described above, three rounds of biopanning were performed
and enrichment level was monitored after each round by
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determining the titre of eluted phages using plaque assay. As
shown in Figure 1A, at the end of three rounds, a gradual increase
in the phage titre led to effective enrichment of the order of 106.
Such high enrichment indicated that a small number of phages
that specifically interact with C. albicans cells are highly represented
in the bound phages. We isolated individual phage clones and
initiated further characterization. A total of 50 well isolated
plaques (labelled as H-1 to H-50) were picked and amplified to
261011 pfu/ml.
Differential binding of phage clones to yeast versus
hyphal cells of C. albicans
Although the phage clones were selected for binding against
hyphal form of C. albicans cells, some of the clones might have
ability to bind the yeast form as well, since cells induced to form
hyphae are associated with their mother cells which are in the
yeast form. There are also some small percent of yeast cells which
have not undergone hyphal transition. Hence we decided to
determine the binding affinity of selected phage clones towards the
two morphological forms. The phage titre after interaction with
equal number of cells either in yeast form or hyphal form reflected
differences in affinity of binding between the different phage clones
and the specific C. albicans morphological form. Out of 50 phage
clones, H-34 showed high level of specific binding to both yeast
and the hyphal form of cells compared to M13 phage displaying
no peptide (Fig. 1B). We observed significant variation in the
affinity of various phage isolates. Seven clones (H-7, 9, 14, 23, 27,
35 and 42) showed very high level of specificity towards hyphal
cells as compared to yeast cells, while sixteen clones (H-5, 6, 8, 11,
12, 13, 15, 16, 17, 18, 20, 29, 37, 41, 45 and 48) showed low level
of affinity with either yeast/hyphal cells with titre values not
significantly different than M13 phage. Remaining 27 clones
showed 10 to 100 fold higher binding with yeast or hyphal cells as
compared to M13. These were considered as moderately specific
clones and pursued further for detailed analysis along with the 7
hyphal specific clones.
Sequencing of selected phage clones showed
enrichment of a few peptide sequences
Out of these 50 clones, 34 positive phage clones (7 highly hyphal
specific and 27 moderately specific to either yeast/hyphal form)
and 2 clones (H-15 and H-41) showing no significant binding,
were used to isolate single-stranded DNA [11]. The region of the
phage genome (N-terminal of g-III region) that encodes the
inserted 12-mer peptide was sequenced and the amino acid
sequence of the peptide was deduced for each clone. The amino
acid sequences revealed a total of 11 different peptide sequences,
of which only 5 sequences were represented in multiple clones
(Table 1). The consensus sequence ‘‘SE*****I*T**’’ predom-
inated among the clones binding highly specifically to the hyphal
cells, while ‘‘EL*A**I/V*****’’ was predominant in clones
binding to hyphal cells only slightly better than the yeast cells. We
Figure 1. Selective enrichment of phages through biopanning. A) Phage peptide library against C. albicans hyphal cells after 3 rounds of bio
panning. Gradual increase in phage titres was observed during first (6.86102 pfu), second (16107 pfu) and third round (16109 pfu) of bio panning.
B) Plaque assay to determine binding specificity of clones to yeast (black bars) or hyphal (grey bars) form cells. Y axis represents the number of
phages bound to 56106 cells. M13 phage without peptide served as a negative control.
doi:10.1371/journal.pone.0016868.g001
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selected 7 phage clones based on their differential binding abilities
for further studies.
The peptides confer high specificity towards C. albicans
cells
Since the present study was initiated with the objective of
developing a simple assay for detection of C. albicans, we decided to
use these phage clones for development of an ELISA and compare
it with ELISA using a commercially available antibody raised
against C. albicans. Since most other related species do not readily
form hyphae under disease condition, it is challenging to
distinguish C. albicans from other Candida spp., in its yeast form.
Hence, we used yeast cells of C. albicans, C. dubliniensis, C. glabrata,
C. kefyr, C. parapsilosis and C. tropicalis to test the specificity of the
phage clones. The microtitre wells were coated with 56106 cells of
the Candida species in yeast form, blocked with 2% BSA for
1 hour at 37uC and the ELISA was carried out using the
commercially available polyclonal anti C. albicans antibody. The
colour developed with OPD/H2O2 as substrate indicated the
strength of interaction. Surprisingly, this antibody showed
interaction with all the Candida species tested. C. albicans, C. kefyr,
and C. dubliniensis cells showed greater reactivity to the antibody,
than the C. tropicalis, C. glabrata and C. parapsilosis with as high as
56106 cells (Fig. 2A).
Subsequently, we performed ELISA using 7 phage clones
described above, including hyphal form specific clones H7 and
H9; as well as both yeast and hyphal form interacting clones H1,
H22, H31, H34 and H49. Since the Candida cells coated were in
the yeast form, except for the hyphal specific clones #7 and #9,
all other clones showed several fold higher level of binding to C.
albicans as compared to all other species (Fig. 2B). The M13 phage
without any peptide insert showed minimal or no binding.
Monitoring both the germ tube formation and growth on
CHROMagar we confirmed that the species used showed
expected phenotypes e.g. only C. albicans and C. dubliniensis formed
germ tubes at 37uC in the presence of serum with significant
quantitative difference in germ tube formation between C. albicans
and C. dubliniensis (data not shown). All the Candida species after
incubation at 37uC for 48 hours showed distinct colony colour on
CHROMagar, specific to the respective species as reported earlier
[12]. All these results confirmed that our phage clones can
specifically identify C. albicans even in comparison to a closely
related species like C. dubliniensis.
The C. albicans specific clones show specific binding
even in presence of several fold high level of competing
C. dubliniensis cells
The mortality rate in immunocompromised patients could be
reduced by detection of lower number of C. albicans cells at an
early stage of infection. The sensitivity of ELISA was tested with C.
albicans cells ranging from 56106 to 56103 interacted with 26107
phages (H34). We observed more than 10 fold reduction in
absorbance at 490 nm and there was no detectable interaction
with less than 56103 cells (data not shown). This showed that in
the current form, the ELISA could detect upto 56103 cells
(Fig. 3A). M13 was used as a negative control which showed no
detectable interaction with the C. albicans cells.
Since we showed that the clones selected above could bind
specifically to C. albicans cells, we decided to test the specificity of
interaction in more stringent conditions. We mixed the C. albicans
cells with the closely related species, C. dubliniensis in several
different ratios and then carried out the ELISA test as described
above. Even at the ratio of 50:1 C. dubliniensis: C. albicans cells, we
observed highly specific binding of the H34 clone with the C.
albicans cells in the yeast form. Thus, we could easily detect as low
as 16105 cells (Fig. 3B). Further reduction of C. albicans cells
showed overall reduced level of interaction (data not shown) and
we suspect that the binding of cells was potentially due to
inefficient binding of the C. albicans cells to the well surfaces used
for ELISA.
Yet another way to confirm the specificity was to test if the
bound phages continue to show species specificity after elution
which should show enrichment of phages. We tested this by first
interacting H34 phage clone with either of the species, eluted the
bound phages and allowed them to interact with the cells of both
the species again. As before, we saw that clone H34 binds
specifically to C. albicans but do not bind to C. dubliniensis cells
(Figure 3C). However, there was no significant interaction with C.
dubliniensis either in the first or second round.
Immunofluorescence assay confirms surface binding of
the phage clones
To support the observations reported above through ELISA, we
tested the ability of some of these clones to bind to the yeast Vs
hyphal cells using immunofluorescence assay. We incubated the
cells in either yeast or hyphal form independently, with the phage
clones and performed immunofluorescence assay as described in
the materials and methods section. Figure 4A shows representative
clones which showed specific interactions with yeast or hyphal
cells. We saw that clone H7 showed only hyphal specific staining
such that even the mother cells from which hyphae had emerged,
showed no staining; on the other hand, H34 clone bound with
both yeast and hyphal forms equally well (Fig. 4A) thus confirming
the specificity of interaction with the morphological forms.
Interestingly, after hyphal induction the H22 clone showed intense
staining of a region of hyphae close to the mother cell and weaker
staining over the rest of the hyphal surface while the mother cells
showed almost no staining (Fig. 4B; left panel). The yeast form
cells however showed a patchy staining (Fig. 4B; right panel). This
indicated that during hyphal induction H22 binding epitopes may
be getting redistributed over different regions of the cell surface.
Table 1. Peptide sequences differ significantly with their
ability to bind either yeast or hyphal cells.
No. Sequences Phage clones Binding efficiency
1 ELMAVPVPLPPA H01 # A H<Y
2 SEYTSQLIFTAT H07 # B H..Y
3 SEFSYIVIDTSL H09 # C H..Y
4 ELTAILVSPAPL H22# D H<Y
5 ELNAQHIMEPKY H49 # E H<Y
6 ELIPMLIMQSTS H46 H<Y
7 EDYSTIMKTLAH H25 H<Y
8 STPKSPHSVASH H38 H<Y
9 AVQHNPTHPFYP H40 H<Y
10 AHSTGLSPSTLR H15 Poor binders
11 TMSSVAPRNLSS H41 Poor binders
.., Highly specific; <, moderate binding. H, Hyphal cells; Y, yeast cells.
(#- subset;Group AH-01, 24, 32, 36, 44; Group B- H-07, 14, 23; Group C- H-09, 27,
35, 42; Group D- H-03, 19, 21,22, 28, 31, 34, 43; Group E- H-02, 04, 10, 26, 30, 33,
39, 47, 49, 50).
doi:10.1371/journal.pone.0016868.t001
Candida albicans Specific Peptides for Diagnosis
PLoS ONE | www.plosone.org 3 February 2011 | Volume 6 | Issue 2 | e16868
Since it is likely that one could encounter C. albicans in blood
samples, to test if we could detect the cells in a sample mimicking
the samples in the field, we mixed the C. albicans cells in blood (see
Materials and Methods) and then smeared the samples on to glass
slides. After performing immunofluorescence study as described
above, we could specifically detect the C. albicans cells without any
other background (Figure S1). This suggested that our reagents
will not react with other components of mammalian blood.
The H34 clone binds a carbohydrate moiety on the cell
surface on C. albicans cells
Since the phages showed specific binding on C. albicans cell
surface we tested if the specificity of binding could be attributed to
carbohydrate or proteinacious moieties on the cell surface. We
treated the cells with either sodium metaperiodate or proteinase K,
as described above and then performed immunofluorescence assay
using clone H34. We observed that proteinase K treated cells
continued to show fluorescence associated with the cell surface,
while sodium metaperiodate treated cells showed no fluorescence
at all, indicating complete loss of phage interaction (Fig. 5A). M13
phage without peptides showed no fluorescence associated with
either untreated or treated cells.
To check further if excess specific monosaccharides will inhibit
the specific binding of phage clones, we performed the sugar
inhibition assay as described in the materials and methods section.
We could see high level of inhibition (upto 100 fold) with 1 M of
galactose and mannose but only a moderate level of inhibition with
dextrose (Fig. 5B). We observed no inhibition with 1 M N acetyl
glucosamine, a component of chitin, the innermost layer of the
fungal cell wall. We also saw no inhibition with either a-D-methyl
mannopyranoside, or lower concentration (1024 M) of galactose or
mannose (Fig. 5C). In all these experiments M13 binding was not
affected by presence of excess of these carbohydrates.
Thus we conclude that the peptide in clone H34 specifically
bound to some carbohydrate moiety which either has galactose or
mannose as one of the components on the cell wall of C. albicans cells.
Discussion
Phage display technique has proved to be a versatile and reliable
tool for selecting short peptides against many biological or non
biological targets [13]. With the rapid development of the
technique over the past decade, phage display has been used
successfully in numerous applications, including antibody engi-
neering [14], peptide and protein drug discovery and manufacture
[15], vaccine development [16] and identification of ligands [17].
Phage display screen has been reported against whole cells as well
as against whole viruses [18],[19].
Figure 2. Interaction of different Candida species with A) commercially available polyclonal anti C. albicans antibody or B) phage
clones. Only yeast form of cells of the indicated Candida species was used. A490 values signify the strength of interaction.
doi:10.1371/journal.pone.0016868.g002
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In the present study, we successfully used phage library
displaying 12 mer random peptides to select C. albicans specific
peptides. While two of these were highly specific to the hyphal
form of cells, 5 peptide clones, showed comparable level of binding
with both yeast and hyphal cells. Of course it is important to
remember that hyphal cells provide much larger surface area for
Figure 3. The phage clone can specifically detect low numbers of C. albicans cells. A) C. albicans cells were serially diluted from 106 to 103
and coated on the microtitre plate. M13 was used as a negative control. B) C. albicans cells were mixed with C. dubliniensis in different ratios keeping
the total number of cells coated to be ,56106 per well. The actual number of each type of cell is indicated below each bar. Anti Candida antibody
which detects both species was used as a control to test for overall equal number of cells coated. C) Primary binding of 109 phages with 106 cells was
estimated by plaque assay. The bound phages after elution were directly interacted with either C. albicans or C. dubliniensis during secondary
interaction. Ratio of bound phages of H34 to M13 was determined during either primary or secondary interaction. Cells were visualized at 800X
magnification.
doi:10.1371/journal.pone.0016868.g003
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binding than the same number of yeast cells. Hence the level of
hyphal binding as indicated by the ELISA may be an over
estimate in favour of the hyphal cells. It is not inconceivable to
imagine that there are identical epitopes present on both yeast and
hyphal cells. It shall be noted that, these peptides do not bind to
any other Candida species including C. dubliniensis, which closely
resembles C. albicans with respect to genome composition and
phenotypes. This indicates that the peptides bind to epitopes
highly specific to C. albicans, thus making these peptides unique
and versatile reagents for diagnosis of C. albicans. We have
determined that at least some of these highly specific epitopes are
carbohydrate in nature. It was interesting that the carbohydrate
moiety detected by the phage clone H34 at least partially had
galactose or mannose as one of its component. Glucose which is
structurally closely related but distinct could inhibit only to
moderate level. It is well documented that the yeast and hyphal
cell walls differ in composition of mannan which form the
outermost layer of the cell wall in C. albicans. It is not surprising
Figure 4. Immunofluorescene assay shows morphology specific binding of phage clones. A) The clone H7 can distinguish between the
yeast mother cells and the hyphae emanating from them while clone 34 exhibits equal binding with both yeast and hyphal form of C. albicans.
B) Clone 22 binds to specific regions on the surface of C. albicans cells. The fluorescent image and the merge of fluorescent and brightfield image are
shown for cells induced to form hyphae (left panel) and yeast cells (right panel).
doi:10.1371/journal.pone.0016868.g004
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that the epitopes differ among different species, which might
reflect subtle differences in carbohydrate metabolism and cell wall
biogenesis in these related Candida species.
For convenient identification of Candida spp. germ tube and
chlamydospore formation as well as sugar assimilation tests, have
been used for a long time [20]. In addition to these conventional
methods, molecular methods including PCR based amplification
of highly conserved sequences in the genome is also reported [6],
[7]. Only germ tube formation test is widely employed in most of
the clinical laboratories for rapid identification of C. albicans.
However, it has been reported that C. dubliniensis, C. parapsilosis, C.
tropicalis can also form germ tubes/pseudohyphae in serum and
their sugar assimilation patterns are similar to that of C. albicans,
hence chances of incorrect diagnosis are high without a test that
can unequivocally differentiate between these related species in a
short time [4].
The two species C. albicans and C. dubliniensis are highly similar
with respect to their genome sequences and exhibit high similarity
in many phenotypic characters including resistance to cyclohex-
imide, ability to produce germ tubes, chlamydospores and true
hyphae [21]. Although sugar assimilation, growth at elevated
temperature and intracellular b-glucosidase activities differ
between these two species [22], [23], none of these methods have
proved to be effective in differentiating the two species in clinical
settings [24]. On the other hand, no single molecular fingerprint-
ing technique has evolved as a dominant method, as each method
has its own set of limitations [25], [26]. Most PCR based methods
often turn out to be too sensitive and while they claim to be able to
Figure 5. Biochemical characterization of cell surface ligands. A) C. albicans cells treated with proteinase K or NaIO4 followed by interaction
with H34 clone showed binding insensitive to the proteinase treatment. M13 used as a negative control showed no interaction with untreated or
treated cells. Cells were visualized at 800X magnification. B) Presence of excess of some monosaccharides inhibits the peptide- cell interactions.
Phage clones incubated with excess (1 M) of Glucose (D), Galactose (G) Mannose (M), and N acetyl glucosamine (N) were allowed to interact with C.
albicans yeast cells and the extent of interaction (or fold inhibition) was determined by plaque assay. C) Inhibition by excess monosaccharides is
concentration and isomer dependent. In the same assay as in B, Mannose or a2D–methyl mannopyranoside used at 1 M and galactose or mannose
at 1024 M concentration and inhibition was determined as above. Values shown represent an average of three readings.
doi:10.1371/journal.pone.0016868.g005
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detect as low as single cell per ml, even degradation products from
dead cells can lead to false positives in these tests. Bliss et al. (2003)
reported identification of ScFv expressing phage clones that could
differentiate between filaments formed by these two species [27].
These reagents were specific to proteins expressed on the filaments
by either of the species. In contrast, some of the peptides reported
in the present study could detect specific carbohydrate moieties on
the surface of C. albicans irrespective of the morphological form
while others could specifically detect ligands on the hyphal form of
C. albicans. Some of the peptides curiously could even decorate
specific domains on hyphae e.g. clone H22 which stains heavily on
surface of hyphae close to the mother cell. While the clones thus
can be used in a diagnostic test, studying specificity of interaction
of H22 will serve an academic interest, since it can differentiate
different regions of surface of Candida hyphae. Hence, not only can
these peptides be used in combination for developing highly
sensitive diagnostic tests, they can be used in studying finer
qualitative differences in surface carbohydrates of these fungal
pathogens which could contribute differently to the host pathogen
interactions. These peptides can be employed for rapid detection
of C. albicans by a simple ELISA based assay which allows testing
multiple samples at the same time and thus making the assay high-
throughput.
Among systemic fungal infections, 60% are caused by C. albicans
and there is an increase in the number of cases of infection due to
non-albicans species like C. tropicalis, C. parapsilosis, C. glabrata and
C. krusei [5]. Since these species differ in their antifungal
susceptibilities and the cost of antifungal treatment is high, it is
imperative to make accurate and timely diagnosis of the causative
agent. Therefore, it is crucial to develop species specific diagnostic
test for all of these species and we believe that, this can be possible
with short peptides identified by phage display technique as
reported here.
Materials and Methods
Candida strains, culture and experimental condition
Clinical isolate of C. albicans, SC5314 [28] was used for phage
peptide library screening. Other Candida species used for
comparative binding studies were C. glabrata (Dr Rupinder Kaur,
CDFD, Hyderabad), C. dubliniensis, and C. tropicalis (Dr Kaustuv
Sanyal, JNC, Bangalore), C. albicans, C. parapsilosis and C. kefyr (Dr.
Y Prakash, KMC, Manipal). Candida strains were routinely grown
in YEPD broth (1% Yeast extract, 2% Peptone, 2% Dextrose)
overnight at 30uC. Under these conditions all Candida strains
grow extensively as yeast cells. CHROMagar (Difco) was used for
identification of Candida species.
C. albicans hyphal induction
For hyphal induction, 56106 yeast cells of C. albicans were
incubated in synthetic complete drop-out medium [29] supple-
mented with 4% glucose and 10% fetal bovine serum (FBS; Gibco-
BRL) at 37uC for 4 hours on a rotary shaker.
Phage libraryand biopanning of phages binding
specifically to C. albicans
Phage library used in this study, contained M13 phage clones
displaying 12 mer random peptides fused to pIII coat protein (New
England Biolabs). Biopanning and amplification of the phages was
performed according to the procedure recommended by the
manufacturer. In brief, 56106 C. albicans cells induced to form
hyphae, were blocked with 2% BSA for 2 hours at room
temperature (RT) and later washed with Tris buffer (TBS pH
7.3) in 1.5 ml eppendorf tubes. Phage library was diluted in
blocking buffer (TBS pH7.3, 2% BSA) and 1011 pfus of the phage
library were co-incubated with ,56106 hyphal cells at RT for
2 hours on a rotator. Unbound phages were washed with TBST
buffer (TBS pH 7.3, 0.1% Tween 20). The bound phages were
eluted with 80 ml of 0.1 M glycine (pH 2) for 10 min and
neutralized with 20 ml of 1 M Tris buffer pH 8.0. The eluted
phages were serially diluted and used to infect E. coli (ER-2738)
and plated on LBTet plates to estimate the titre values. After first
round of panning, eluted phages were amplified to a concentration
of 261011 pfu/ml and again used as input for second round of
biopanning. Second and third round was each performed in the
same way as the first round, except that 0.3% and 0.5% Tween-20
was used respectively during washing step to increase the
stringency of binding of peptides to the cells. After the third
round of selection, individual plaques on LB plates were picked
with sterile tooth pick and maintained as individual phage clones
for further studies.
Assays for detection of peptide dependent phage
binding to C. albicans cells
Plaque assay. Binding studies of individual phage clones
with C. albicans cells (both yeast and hyphal form) were performed
to select phage clones which show specific binding. Binding of
individual phage clones was confirmed by plaque assay performed
in triplicate. In brief, 56106 cells of C. albicans in either yeast or
hyphal form, were mixed with a single phage clone having 26109
pfu/ml phages in an eppendorf tube and incubated at RT for
1 hour. Unbound phages were removed by three washes with
TBST buffer (0.5% Tween 20 in TBS) followed by two washes
with TBS. Bound phages were eluted with 80 ml of 0.1 M glycine
(pH 2.0) for 10 min and immediately neutralized with 20 ml of
1 M Tris buffer pH 8.0. Phage titre was estimated as above. In all
experiments M13 phage without displaying any peptide was used
as negative control.
Specificity of H34 phage clone was further conformed by two
rounds of plaque assay against 56106 cells of C. albicans or C.
dubliniensis as mentioned above. In the first round, 26109 pfu/ml
phages were used for the interaction, whereas in the second round,
the eluted phages obtained from the first round estimated as
26107 pfu were used. The plaque assay in which 56106 cells of C.
albicans or C. dubliniensis were interacted with 26107 pfu/ml phages
used as a control and M13 phage was used as a negative control.
ELISA. Phage clones were further tested by ELISA for their
ability to bind specifically to C. albicans. All ELISA tests were
performed in triplicate in 96 well poly-lysine coated microtitre
plates. All wells were incubated with 100 ml of 56107/ml yeast
cells of C. albicans at 37uC for 1 hour. After decanting, wells were
blocked with 2% BSA for 1 hour at 37uC and then 26107 pfus of
individual phage clone in 100 ml of TBS were added to each well.
After 1 hour incubation at RT on orbital shaker, wells were
washed once with 0.5% TBST and incubated for 1 hour with
100 ml of mouse antiM13 horseradish peroxidase (HRP) conjugate
(GE Healthcare, Munchen, Germany: 1:15000) at RT on orbital
shaker. The wells were washed once with 0.1% TBST and
presence of HRP was detected with o- phenylene diamine (OPD)/
H2O2 as substrate. The reaction was stopped by addition of 50 ml
of 2.5 M sulphuric acid. Absorbance at 490 nm was measured by
using ELISA plate reader (SPECTRAmax 340).
As control ELISA was performed using rabbit polyclonal anti C.
albicans antibody (Takara Bio Inc), as primary antibody (1:2,000),
instead of phage clones and anti rabbit HRP conjugate (1:15,000)
(Sigma) was used as the secondary antibody to detect the primary
antibody bound to Candida species cells. Peroxidase level was
determined as described above.
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Competitive ELISA. To check the sensitivity and specificity
of the assay, we mixed the C. albicans and C. dubliniensis in
different ratios (numbers) as well as C. albicans alone coated on the
well and performed the ELISA experiment as described above.
Immunofluorescence assay. Yeast form of C. albicans cells
were spotted and incubated at 37uC for 1 hour on poly lysine
coated glass slides. Non specific binding sites were blocked with
2% BSA for 1–2 hours at 37uC. Cells were spotted and incubated
with 26109 pfu of specific phage clone in 100 ml of TBS for
1 hour at RT on rocker. Phages were washed off once with 0.1%
TBST and cells were incubated with HRP conjugated mouse anti
M13 antibody (1:100 dilution) at RT. After 1 hour incubation,
cells were washed once with TBS and incubated with 1:1000
dilution of anti-mouse antibody-FITC conjugate for 1 hour on
rocker at RT. Slides were rinsed with TBS and observed using
Olympus B51 fluorescence microscope.
Yeast form of C. albicans cells in the presence of blood were
spotted on poly lysine coated glass slide and incubated at 37uC for
1 hour. The debris was removed by washing with 1X TBS. Cells
were interacted with 26109 pfu of specific phage clone in 100 ml of
TBS for 1 hour at RT on rocker and immunofluorescence was
performed as described above.
Sugar inhibition assay. To test whether the binding of phage
clones on involves interaction with sugar residues the cell wall of C.
albicans, we performed the interactions in presence of high
concentration of various monosaccharides. The phage clones
(26107 pfu) were mixed with 1 M of dextrose, galactose,
mannose or N-Acetyl glucosamine in an eppendorf tube for 1 hr
at RT. Then 56106 C. albicans cells were added to the tube for
interaction and the plaque assay was performed as described above.
M13 phage was used as a negative control. The above experiment
was performed with 1 M of a-D-methyl mannopyranoside, 10-4 M
of galactose or mannose.
Biochemical analysis of peptide binding specificity.
Overnight saturated C. albicans cells were washed with TBS
and treated with either proteinase K to degrade proteinaceous
antigens or with sodium metaperiodate to degrade carbohydrate
antigens on the cell surface as described previously [27]. Briefly,
for proteinase K treatment cells were incubated in 50 mM Tris
(pH 7.5) containing 100 mg/ml of proteinase K for 2 h at 37uC.
For sodium metaperiodate treatment, cells were incubated in
50 mM sodium acetate (pH 4.5) buffer containing 50 mM sodium
metaperiodate for 30 min at 4uC in the dark. After washing with
water, treated cells were analyzed by immunofluorescence as
described above.
Supporting Information
Figure S1 Immunofluorescence assay shows that Can-
dida specific phages do not react with components of
mammalian blood. As described in the methods section the
cells mixed with rabbit blood were smeared and immunofluores-
cence assay was performed with H34 phage clone. Cells were
visualized at 800X magnification. The brightfield image, the
fluorescent image and the merge of the two are shown.
(TIF)
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